Wegovy weight loss results — Emma’s honest 6-month semaglutide review.

Emma is a 38-year-old marketing director from Bristol. She describes herself as someone who has been at war with food since her mid-twenties — not in a dramatic clinical sense, but in the exhausting, persistent way that many women recognise: constantly thinking about what she had eaten, what she was about to eat, what she should not eat. She had a healthy diet by most objective measures. She was not a binge eater. She simply never felt satisfied, never felt in control, and carried the same 2.5 stone she had been trying to lose for six years. Her Wegovy weight loss results over the six months from December 2025 to June 2026 surprised her — not because of the number on the scale, but because of what changed in her head.

This is Emma’s story — her month-by-month Wegovy weight loss results, the side effects she managed, what changed beyond the scale, and what she wishes she had known before she started. Her experience is grounded in the real-world evidence: a landmark August 2025 study published in Advances in Therapy analysing 13,000+ Wegovy patients enrolled in the WeGoTogether support programme found average weight loss of 13.4% at 6 months and 17.6% at 12 months. Emma’s Wegovy results fall right in line. Full guidance follows the NHS healthy weight management guidance and NHS semaglutide injection guidance.

Before Wegovy — Emma’s starting point

“I was a healthy eater who was still overweight,” Emma told us. “I ate well during the day. I tracked calories for months at a time. I lost weight, then gained it back. Every time I stopped tracking, the weight came back because I couldn’t manage my hunger without the external structure of counting everything. I was exhausted by it. The idea of doing that forever was not a life.”

Emma started Wegovy in December 2025 after reading about the STEP-1 trial results and speaking to her GP. Her BMI was 31. She had no significant medical risk factors but significant quality-of-life impact from her weight and her relationship with food. She ordered through Mymetabolism and started her first 0.25mg injection in the second week of December. Her Wegovy weight loss results month by month are detailed below.

Month-by-month Wegovy weight loss results

The food noise change — Emma’s most important Wegovy result

Ask Emma about her Wegovy weight loss results and she will talk about the scale for approximately thirty seconds before moving on to the thing she actually cares about: the food noise. “Food noise” — the constant background mental chatter about food, eating, hunger, and restraint that occupies a disproportionate amount of mental bandwidth for many overweight people — is one of the most commonly reported experiences before GLP-1 treatment and one of the most dramatic changes during it.

“Within ten days of the first injection, the noise was quieter. By month two it was almost gone. I would get to two in the afternoon and realise I hadn’t thought about food since breakfast. That had literally never happened in my adult life. I’m a marketing director — I need my brain for other things. Getting that mental space back was worth more to me than the two stone.”

This experience is not unusual. The GLP-1 mechanism acts on appetite centres in the brain — specifically the hypothalamus and limbic system — not just on gastric emptying. The result for many patients is a fundamental change in how food is perceived and thought about, not just how much of it they consume. This is why the Wegovy weight loss results that matter most to many patients are not captured in a before-and-after photograph.

Side effects — Emma’s honest account

Emma experienced more pronounced side effects than James in the Ozempic story — reflecting Wegovy’s higher dose at the 2.4mg maintenance level. Her honest account:

• Nausea (months 2 and 5 at dose escalations): “The 1mg escalation in month 2 was the worst two weeks I had. Not vomiting, but constant low-grade queasiness that made food unappealing and made me tired. The 2.4mg escalation in month 5 was milder because I knew what to expect and managed my food and hydration better. Plain food on injection day and the day after was essential.”
• Constipation (months 1–3): “Significant. I added a lot more fibre, drank a lot more water, and ate prunes daily. It resolved by month 3 but was the most annoying part of the first few months.”
• Fatigue (months 1–2): “I was more tired than usual for the first 6 weeks. I stopped my usual HIIT classes and walked instead. By month 3 my energy was better than it had been before I started — probably because I was eating better and sleeping better.”
• Hair thinning (noticed in month 4): “Some extra shedding. I increased my protein significantly — the support team had warned me about this and I’d been underestimating my protein needs. The shedding reduced within 3 to 4 weeks of getting protein intake up to around 120g daily.”

What made the difference in Emma’s Wegovy journey

Emma identifies five specific decisions that she believes separated her Wegovy weight loss results from the more modest real-world averages:

• Using the Mymetabolism support team proactively — “I messaged before problems became crises. When the hair thinning started I messaged immediately. The protein advice came back within an hour and solved the problem within weeks.”
• Starting Pilates at month 3 — “I chose Pilates specifically because the support team said resistance exercise preserves muscle. I’d never done it before. I now do two sessions a week and the change in my body shape has been as significant as the weight loss.”
• Not eating past 8pm — “A natural intermittent fasting window appeared without me planning it. The Wegovy suppressed my evening appetite so completely that I simply stopped eating after dinner. I didn’t make a rule — it just happened. But it made a difference.”
• Protein tracking for the first 8 weeks — “I tracked protein only — not calories — for the first 8 weeks. Hitting 110g to 120g per day was hard on a reduced appetite but manageable. After 8 weeks I knew what my meals needed to look like and stopped tracking.”
• Being honest about the side effects with her partner — “My partner knew I was more tired and more nauseated in the first few weeks. He adjusted what he cooked and didn’t question why I wasn’t finishing meals. Support makes it easier.”

Realistic Wegovy weight loss results in 2026

Emma’s Wegovy weight loss results — 2 stone (13.9% of starting body weight) in 6 months — align closely with the most reliable real-world data available. The WeGoTogether programme analysis published in Advances in Therapy in August 2025, covering 13,000+ patients taking semaglutide 2.4mg, found average weight loss of 13.4% at 6 months. The STEP-1 clinical trial showed 14.9% at 68 weeks. Emma’s 6-month result sits right in the middle of both benchmarks.

The most important context for anyone considering Wegovy in 2026 is the June 11 2026 MHRA approval of an oral semaglutide tablet (Wegovy pill) — the first GLP-1 weight loss pill approved in the UK. For patients who prefer not to self-inject, this represents a major new option with comparable efficacy to the injectable form. Browse our full product range, read our verified customer reviews, and see our How Long Does Wegovy Take to Work guide for more on what to expect from treatment.